SCHEMBL3172939

SCHEMBL3172939

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3cnccn3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 4/20 0.44
▸ DRD4 P21917 4/20 0.44
▸ DRD3 P35462 3/20 0.44
▸ THRB P10828 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KDM6B O15054 2/20 0.43
▸ NR1I2 O75469 1/20 0.43
▸ CHRNA1 P02708 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ OPRM1 P35372 1/20 0.43
▸ AHR P35869 1/20 0.43
▸ AVPR1A P37288 1/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ PDE4B Q07343 1/20 0.43
▸ SCN5A Q14524 1/20 0.43
▸ KDM2B Q8NHM5 1/20 0.43
▸ KDM4C Q9H3R0 1/20 0.43
▸ KDM5B Q9UGL1 1/20 0.43
▸ PHF8 Q9UPP1 1/20 0.43
▸ SLCO1B1 Q9Y6L6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3172350 0.91 THRB (0.55) DRD2DRD4DRD3THRBNPSR1
SCHEMBL3160939 0.88 ALDH1A1 (0.52) DRD2DRD4DRD3THRBNPSR1
SCHEMBL3162425 0.86 EGFR (0.53) ALDH1A1TSHRLMNAKDM4ESMN1; SMN2
SCHEMBL3170421 0.85 SMN1; SMN2 (0.55) ALDH1A1TSHRKDM4ETDP1SMN1; SMN2
SCHEMBL3177057 0.84 AURKA (0.41) ALDH1A1TSHRCYP1A2CYP3A4CLK4
SCHEMBL3171437 0.84 CYP1A2 (0.46) DRD4NPSR1KDM6BNR1I2CHRNA1
SCHEMBL3171920 0.84 ADORA1 (0.47) ALDH1A1KDM4EGSK3BDYRK1AADORA2A
SCHEMBL3163144 0.83 ADORA3 (0.46) ALDH1A1TSHRLMNAKDM4ESMN1; SMN2
SCHEMBL3163125 0.83 NPC1 (0.47) NPSR1ALDH1A1KDM4EGSK3BDYRK1A
SCHEMBL3164709 0.83 NPC1 (0.47) NPSR1ALDH1A1KDM4EGSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback